170 related articles for article (PubMed ID: 38084840)
1. Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer.
Davies GCG; Dedi N; Jones PS; Kevorkian L; McMillan D; Ottone C; Schulze MED; Scott-Tucker A; Tewari R; West S; Wright M; Rowley TF
MAbs; 2023; 15(1):2289681. PubMed ID: 38084840
[TBL] [Abstract][Full Text] [Related]
2. Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways.
Tumelty KE; Higginson-Scott N; Fan X; Bajaj P; Knowlton KM; Shamashkin M; Coyle AJ; Lu W; Berasi SP
J Biol Chem; 2018 Mar; 293(9):3039-3055. PubMed ID: 29317497
[TBL] [Abstract][Full Text] [Related]
3. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
4. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
[TBL] [Abstract][Full Text] [Related]
5. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-to-mesenchymal transition (EMT) in HK-2 cells.
Li Y; Wang Z; Wang S; Zhao J; Zhang J; Huang Y
Toxicology; 2012 Jul; 297(1-3):68-75. PubMed ID: 22525892
[TBL] [Abstract][Full Text] [Related]
6. Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion.
Kim M; Yoon S; Lee S; Ha SA; Kim HK; Kim JW; Chung J
PLoS One; 2012; 7(4):e35100. PubMed ID: 22514712
[TBL] [Abstract][Full Text] [Related]
7. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
Kobayashi H; Gieniec KA; Wright JA; Wang T; Asai N; Mizutani Y; Lida T; Ando R; Suzuki N; Lannagan TRM; Ng JQ; Hara A; Shiraki Y; Mii S; Ichinose M; Vrbanac L; Lawrence MJ; Sammour T; Uehara K; Davies G; Lisowski L; Alexander IE; Hayakawa Y; Butler LM; Zannettino ACW; Din MO; Hasty J; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Wang TC; Enomoto A; Takahashi M; Worthley DL; Woods SL
Gastroenterology; 2021 Mar; 160(4):1224-1239.e30. PubMed ID: 33197448
[TBL] [Abstract][Full Text] [Related]
8. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.
Karagiannis GS; Berk A; Dimitromanolakis A; Diamandis EP
Mol Oncol; 2013 Aug; 7(4):826-39. PubMed ID: 23659962
[TBL] [Abstract][Full Text] [Related]
9. Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.
Grillo E; Ravelli C; Corsini M; Ballmer-Hofer K; Zammataro L; Oreste P; Zoppetti G; Tobia C; Ronca R; Presta M; Mitola S
Oncotarget; 2016 Jun; 7(23):35353-68. PubMed ID: 27174917
[TBL] [Abstract][Full Text] [Related]
10. The binding of the bone morphogenetic protein antagonist gremlin to kidney heparan sulfate: Such binding is not essential for BMP antagonism.
Tatsinkam AJ; Rune N; Smith J; Norman JT; Mulloy B; Rider CC
Int J Biochem Cell Biol; 2017 Feb; 83():39-46. PubMed ID: 27979781
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 4 inhibits TGF-beta2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation.
Zode GS; Clark AF; Wordinger RJ
Glia; 2009 May; 57(7):755-66. PubMed ID: 19031438
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
13. Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2.
Zanotti S; Smerdel-Ramoya A; Stadmeyer L; Canalis E
J Cell Biochem; 2008 Jul; 104(4):1421-6. PubMed ID: 18286547
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Gremlin expression in the posterior limb bud.
Nissim S; Hasso SM; Fallon JF; Tabin CJ
Dev Biol; 2006 Nov; 299(1):12-21. PubMed ID: 16989805
[TBL] [Abstract][Full Text] [Related]
15. Structure of Gremlin-1 and analysis of its interaction with BMP-2.
Kišonaitė M; Wang X; Hyvönen M
Biochem J; 2016 Jun; 473(11):1593-604. PubMed ID: 27036124
[TBL] [Abstract][Full Text] [Related]
16. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid Hormone-Related Protein Interacts With the Transforming Growth Factor-β/Bone Morphogenetic Protein-2/Gremlin Signaling Pathway to Regulate Proinflammatory and Profibrotic Mediators in Pancreatic Acinar and Stellate Cells.
Bhatia V; Cao Y; Ko TC; Falzon M
Pancreas; 2016; 45(5):659-70. PubMed ID: 26495794
[TBL] [Abstract][Full Text] [Related]
18. Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis.
Shi W; Zhao J; Anderson KD; Warburton D
Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L1030-9. PubMed ID: 11290528
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
20. Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling.
Tatsinkam AJ; Mulloy B; Rider CC
Biochem J; 2015 Aug; 470(1):53-64. PubMed ID: 26251446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
